Ronald Keith Wray, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 988 Oak Ridge Tpke, Suite 200, Physicians Plaza, Oak Ridge, TN 37830 Phone: 865-483-4366 Fax: 865-483-5957 |
Phillip Morgan Ricks, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Tpke, Suite 200, Physicians Plaza, Oak Ridge, TN 37830 Phone: 865-483-4366 Fax: 865-483-5957 |
Clement H Block Jr., M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Turnpike, St 200, Physicians Plaza, Oak Ridge, TN 37830 Phone: 865-483-4366 Fax: 865-483-5957 |
Kenneth Frederick Luckmann, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Tpke, Suite 200, Physicians Plaza, Oak Ridge, TN 37830 Phone: 865-483-4366 Fax: 865-483-5957 |
Charles F Gholson, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 988 Oak Ridge Tpke, Suite 200, Physicians Plaza, Oak Ridge, TN 37830 Phone: 865-483-4366 Fax: 865-483-5957 |
News Archive
Results of a national study of 304 U.S. physicians, in which "mock" patients' symptoms were presented for diagnosis, suggest that a sizeable percentage of primary care doctors probably fail to properly diagnose and refer patients with chronic kidney disease (CKD).
We appreciate the hard work and long hours the subcommittee has invested in scientific peer review of the FDA's draft safety assessment of the use of BPA in food contact applications.
Researchers at the University of Pennsylvania have demonstrated that morphine withdrawal complicates hepatitis C by suppressing IFN-alpha-mediated immunity and enhancing virus replication.
NextBio and Cancer Care Institute (CCI) announced today a strategic partnership aimed at furthering the adoption of genomics in the clinic. The collaboration will facilitate use of the NextBio platform to interpret genomic molecular data for oncology patients and streamline the complete workflow for use of molecular data in a clinical setting.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $21.0 million of shares of its Series 7 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to four institutional investors.
› Verified 8 days ago